T 0230/08 (BAFF-inhibitors/BIOGEN) of 10.10.2012
- European Case Law Identifier
- ECLI:EP:BA:2012:T023008.20121010
- Date of decision
- 10 October 2012
- Case number
- T 0230/08
- Petition for review of
- -
- Application number
- 00909970.6
- Language of proceedings
- English
- Distribution
- Distributed to board chairmen (C)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- BAFF, inhibitors thereof and their use in the modulation of the B-cell response
- Applicant name
- Biogen, Inc.
Apoxis SA - Opponent name
- 01 - Human Genome Sciences, Inc.
02 - Merck Serono SA - Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 54
- Keywords
- Main request - novelty (no)
- Catchword
- -
- Cited cases
- T 0019/90
- Citing cases
- -
ORDER
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The patent is revoked.